Testosterone cypionate

Drug Profile

Testosterone cypionate

Alternative Names: Andro-Cyp-100; Andro-Cyp-200; Andronaq-LA; Andronate; D-Tes 100; depAndro 100; depAndro 200; Depo; Depo-Testosterone; Depotest; Depotest 100; Depotest 200; Depovirin; Dura-Testosterone; Duratest; Duratest-100; Malogen Cyp; Man-Agin; Meditest; Pertestis; Shotest; T-Cypionate; Testa-C; Testadiate-Depo; Testaspan; Testergon; Testex Leo Prolongatum; Testodrin; Testoject; Testoject-100 LA; Testosterone cyclopentanepropionate; Testosterone cypionate; Testred Cypionate 200

Latest Information Update: 15 Jul 2015

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Pfizer
  • Class Anabolic steroids; Androstenols; Hormonal replacements; Small molecules; Testosterone congeners
  • Mechanism of Action Testosterone agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Marketed Andropause; Breast cancer; Breast disorders; Delayed puberty; Eunuchoidism; Hypogonadism; Oligospermia; Osteoporosis

Most Recent Events

  • 24 Jun 2018 Biomarkers information updated
  • 01 Jul 2014 Forest Laboratories has been acquired by Actavis Inc
  • 04 Jan 2007 Schwarz Pharma has been acquired by UCB
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top